How Will ConforMIS (NASDAQ:CFMS) Stock React to The Latest Coverage By Sterne Agee CRT?

Share

How Sterne Agee CRT Currently Rates ConforMIS (NASDAQ:CFMS)

Analysts at Sterne Agee CRT have begun coverage for shares of ConforMIS (NASDAQ:CFMS) in a very recent research note shared with investors on Tuesday, 1 December. The equities firm set a “Buy” rating on the $879.18M market cap firm.

From a total of 4 analysts covering ConforMIS Inc (NASDAQ:CFMS) stock, 5 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is $26 while the lowest target price is $22. The mean of all analyst targets is $24 with a 24.89% above today’s ($21.82) stock price. ConforMIS Inc was the topic of 6 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Oppenheimer maintained shares on August 12 with “Outperform” rating. JP Morgan initiated CFMS stock in a recent report from July 27 with “Overweight” rating. Finally, Canaccord Genuity initiated the stock with “Buy” rating in a report issued on a July 27.

Approximately 31,452 shares of stock traded hands. ConforMIS Inc (NASDAQ:CFMS) has risen 6.00% since November 1, 2015 and is uptrending. It has outperformed by 7.62% the S&P500.

How Will ConforMIS (NASDAQ:CFMS) Stock React to The Latest Coverage By Sterne Agee CRT?

ConforMIS, Inc. is a medical technology company. The company has a market cap of $879.18 million. The Firm uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, to fit each patient’s anatomy. It currently has negative earnings. It is engaged in offering a line of customized knee implants designed to restore the natural shape of a patient’s knee.

According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.” Get a free copy of the Zacks research report on ConforMIS Inc (CFMS)

COMMENTS: